Greg Ciesielski joined HarbourVest in 2007 and has worked on the European, US, and Asia teams. He left the Firm in 2011 and rejoined the London team in 2013 after receiving his MBA. Greg focuses on global secondary investments purchased through both traditional and more complex transactions. He has played a key role in several transactions, including the secondary direct acquisition of 3i’s remaining venture portfolio by DFJ Esprit’s Encore Ventures and the spin out of Phase4 Ventures, the life science venture capital business of Nomura.
Prior to HarbourVest, Greg worked at Bear Stearns & Co. Inc. as an investment banking analyst in the Global Healthcare Group in New York.
Greg received a BS in Business with a concentration in Finance from Indiana University in 2005 and an MBA from Columbia Business School in 2013.